NEW YORK – CareDx and Stanford University on Wednesday filed a patent infringement lawsuit against TAI Diagnostics in the United States District Court for the District of Delaware, alleging that TAI's heart transplant rejection test MyTAIHeart infringes on a patent owned by Stanford and exclusively licensed to CareDx covering a method for the non-invasive diagnosis of transplant rejection.